Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Baker, JKL; Elshaw, SR; Mathewman, GEL; Nichols, CE; Murray, AK; Parsons, MA; Rennie, IG; Sisley, K
   Expression of integrins, degradative enzymes and their inhibitors in uvealmelanoma: differences between in vitro and in vivo expression
   MELANOMA RESEARCH
   
   J.K.L. Baker et al., "Expression of integrins, degradative enzymes and their inhibitors in uvealmelanoma: differences between in vitro and in vivo expression", MELANOMA RE, 11(3), 2001, pp. 265-273
2. Fredstorp-Lidebring, M; Bendahl, PO; Brunner, N; Casslen, B; Hogberg, T; Langstrom-Einarsson, E; Willen, R; Ferno, M
   Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
   EUROPEAN JOURNAL OF CANCER
   
   M. Fredstorp-Lidebring et al., "Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer", EUR J CANC, 37(18), 2001, pp. 2339-2348
3. Magnusson, C; Hogklint, L; Libelius, R; Tagerud, S
   Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle
   JOURNAL OF NEUROSCIENCE RESEARCH
   
   C. Magnusson et al., "Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle", J NEUROSC R, 66(3), 2001, pp. 457-463
4. Ichiki, K; Mitani, N; Doki, Y; Hara, H; Misaki, T; Saiki, I
   Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer
   CLINICAL & EXPERIMENTAL METASTASIS
   
   K. Ichiki et al., "Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer", CLIN EXP M, 18(7), 2001, pp. 539-545
5. Shetty, S; Idell, S
   Urokinase induces expression of its own receptor in Beas2B lung epithelialcells
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   S. Shetty e S. Idell, "Urokinase induces expression of its own receptor in Beas2B lung epithelialcells", J BIOL CHEM, 276(27), 2001, pp. 24549-24556
6. Pietruszka, AJ; Rubin, KH; Garcia, MO
   Ra-226-Th-230-U-238 disequilibria of historical Kilauea lavas (1790-1982) and the dynamics of mantle melting within the Hawaiian plume
   EARTH AND PLANETARY SCIENCE LETTERS
   
   A.J. Pietruszka et al., "Ra-226-Th-230-U-238 disequilibria of historical Kilauea lavas (1790-1982) and the dynamics of mantle melting within the Hawaiian plume", EARTH PLAN, 186(1), 2001, pp. 15-31
7. Moir, E; Booth, NA; Bennett, B; Robbie, LA
   Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism
   BRITISH JOURNAL OF HAEMATOLOGY
   
   E. Moir et al., "Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism", BR J HAEM, 113(1), 2001, pp. 72-80
8. Kahr, WHA; Zheng, SL; Sheth, PM; Pai, M; Cowie, A; Bouchard, M; Podor, TJ; Rivard, GE; Hayward, CPM
   Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator
   BLOOD
   
   W.H.A. Kahr et al., "Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator", BLOOD, 98(2), 2001, pp. 257-265
9. Muneer, E; Bell, J; Doctor, VM
   Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator
   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
   
   E. Muneer et al., "Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator", EUR J DRUG, 25(2), 2000, pp. 137-143
10. Pap, G; Eberhardt, R; Rocken, C; Nebelung, W; Neumann, HW; Roessner, A
    Expression of stromelysin and urokinase type plasminogen activator proteinin resection specimens and biopsies at different stages of osteoarthritis of the knee
    PATHOLOGY RESEARCH AND PRACTICE
    
    G. Pap et al., "Expression of stromelysin and urokinase type plasminogen activator proteinin resection specimens and biopsies at different stages of osteoarthritis of the knee", PATH RES PR, 196(4), 2000, pp. 219-226
11. Gunther, A; Mosavi, P; Ruppert, C; Heinemann, S; Temmesfeld, B; Velcovsky, HG; Morr, H; Grimminger, F; Walmrath, D; Seeger, W
    Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease
    THROMBOSIS AND HAEMOSTASIS
    
    A. Gunther et al., "Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease", THROMB HAEM, 83(6), 2000, pp. 853-860
12. Fukao, H; Matsuo, O
    Antithrombotic regulation in human endothelial cells by fibrinolytic factors
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    H. Fukao e O. Matsuo, "Antithrombotic regulation in human endothelial cells by fibrinolytic factors", SEM THROMB, 26(1), 2000, pp. 33-38
13. Huang, GW; Sunagawa, M; Li, JE; Shimada, S; Gang, Z; Tokeshi, Y; Kosugi, T
    The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma
    LARYNGOSCOPE
    
    G.W. Huang et al., "The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma", LARYNGOSCOP, 110(12), 2000, pp. 2066-2069
14. Lijnen, HR; Arza, B; Van Hoef, B; Collen, D; Declerck, PJ
    Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3)
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    H.R. Lijnen et al., "Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3)", J BIOL CHEM, 275(48), 2000, pp. 37645-37650
15. Podor, TJ; Peterson, CB; Lawrence, DA; Stefansson, S; Shaughnessy, SG; Foulon, DM; Butcher, M; Weitz, JI
    Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    T.J. Podor et al., "Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin", J BIOL CHEM, 275(26), 2000, pp. 19788-19794
16. Zou, HB; Zindler, A
    Theoretical studies of U-238-Th-230-Ra-226 and U-235-Pa-231 disequilibria in young lavas produced by mantle melting
    GEOCHIMICA ET COSMOCHIMICA ACTA
    
    H.B. Zou e A. Zindler, "Theoretical studies of U-238-Th-230-Ra-226 and U-235-Pa-231 disequilibria in young lavas produced by mantle melting", GEOCH COS A, 64(10), 2000, pp. 1809-1817
17. Chazaud, B; Bonavaud, S; Plonquet, A; Pouchelet, M; Gherardi, RK; Barlovatz-Meimon, G
    Involvement of the [uPAR : uPA : PAI-1 : LRP] complex in human myogenic cell motility
    EXPERIMENTAL CELL RESEARCH
    
    B. Chazaud et al., "Involvement of the [uPAR : uPA : PAI-1 : LRP] complex in human myogenic cell motility", EXP CELL RE, 258(2), 2000, pp. 237-244
18. Fukao, H; Ikeda, M; Ichikawa, T; Inufusa, H; Okada, K; Ueshima, S; Matsuo, O
    Effect of hyperthermia on the viability and the fibrinolytic potential of human cancer cell lines
    CLINICA CHIMICA ACTA
    
    H. Fukao et al., "Effect of hyperthermia on the viability and the fibrinolytic potential of human cancer cell lines", CLIN CHIM A, 296(1-2), 2000, pp. 17-33
19. Condomines, M; Sigmarsson, O
    U-238-Th-230 disequilibria and mantle melting processes: a discussion
    CHEMICAL GEOLOGY
    
    M. Condomines e O. Sigmarsson, "U-238-Th-230 disequilibria and mantle melting processes: a discussion", CHEM GEOL, 162(2), 2000, pp. 95-104
20. Kitange, G; Tsunoda, K; Anda, T; Nakamura, S; Yasunaga, A; Naito, S; Shibata, S
    Immunohistochemical expression of Ets-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas
    CANCER
    
    G. Kitange et al., "Immunohistochemical expression of Ets-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas", CANCER, 89(11), 2000, pp. 2292-2300
21. Robbie, L; Berry, S; Moir, E; Booth, NA; Culligan, D; Tighe, J; Watson, H; King, D; Bennett, B
    Myeloid leukaemic cells can lyse fibrin directly
    BRITISH JOURNAL OF HAEMATOLOGY
    
    L. Robbie et al., "Myeloid leukaemic cells can lyse fibrin directly", BR J HAEM, 111(2), 2000, pp. 524-529
22. Robbie, LA; Dummer, S; Booth, NA; Adey, GD; Bennett, B
    Plasminogen activator inhibitor 2 and urokinase-type plasminogen activatorin plasma and leucocytes in patients with severe sepsis
    BRITISH JOURNAL OF HAEMATOLOGY
    
    L.A. Robbie et al., "Plasminogen activator inhibitor 2 and urokinase-type plasminogen activatorin plasma and leucocytes in patients with severe sepsis", BR J HAEM, 109(2), 2000, pp. 342-348
23. Zhu, FX; He, FC
    Progress in study of structure-function relationship and protein engineering of plasminogen activators
    CHINESE SCIENCE BULLETIN
    
    F.X. Zhu e F.C. He, "Progress in study of structure-function relationship and protein engineering of plasminogen activators", CHIN SCI B, 44(4), 1999, pp. 289-294
24. Wu, WJ; Yamaura, T; Murakami, K; Ogasawara, M; Hayashi, K; Murata, J; Saiki, I
    Involvement of TNF-alpha in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress
    ONCOLOGY RESEARCH
    
    W.J. Wu et al., "Involvement of TNF-alpha in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress", ONCOL RES, 11(10), 1999, pp. 461-469
25. Murakami, K; Yamaura, T; Suda, K; Ohie, S; Shibata, J; Toko, T; Yamada, Y; Saiki, I
    TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantationof Lewis lung carcinoma
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    K. Murakami et al., "TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantationof Lewis lung carcinoma", JPN J CANC, 90(11), 1999, pp. 1254-1261
26. Ueshima, S; Matsumoto, H; Izaki, S; Mitsui, Y; Fukao, H; Okada, K; Matsuo, O
    Co-localization of urokinase and its receptor on established human umbilical vein endothelial cell
    CELL STRUCTURE AND FUNCTION
    
    S. Ueshima et al., "Co-localization of urokinase and its receptor on established human umbilical vein endothelial cell", CELL STRUCT, 24(2), 1999, pp. 71-78
27. Zeitler, P; Schuster, V
    Plasma values for u-PA in children
    EUROPEAN JOURNAL OF PEDIATRICS
    
    P. Zeitler e V. Schuster, "Plasma values for u-PA in children", EUR J PED, 158, 1999, pp. S205-S208
28. Seddighzadeh, M; Zhou, JN; Kronenwett, U; Shoshan, MC; Auer, G; Sten-Linder, M; Wiman, B; Linder, S
    ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation
    CLINICAL & EXPERIMENTAL METASTASIS
    
    M. Seddighzadeh et al., "ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation", CLIN EXP M, 17(8), 1999, pp. 649-654
29. Booyse, FM; Aikens, ML; Grenett, HE
    Endothelial cell fibrinolysis: Transcriptional regulation of fibrinolytic protein gene expression (t-PA, n-PA, and PAI-1) by low alcohol
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    
    F.M. Booyse et al., "Endothelial cell fibrinolysis: Transcriptional regulation of fibrinolytic protein gene expression (t-PA, n-PA, and PAI-1) by low alcohol", ALC CLIN EX, 23(6), 1999, pp. 1119-1124
30. Fareed, J; Hoppensteadt, DA; Jeske, WP; Ahmad, S; Bick, RL
    Acquired defects of fibrinolysis associated with thrombosis
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    J. Fareed et al., "Acquired defects of fibrinolysis associated with thrombosis", SEM THROMB, 25(4), 1999, pp. 367-374
31. Pathak, PN; Veeraraghavan, R; Ruikar, PB; Manchanda, VK
    Solvent extraction studies on Th(IV), Pa(V) and U(VI) from nitric acid medium using di-2-ethyl hexyl isobutyramide (D2EHIBA)
    RADIOCHIMICA ACTA
    
    P.N. Pathak et al., "Solvent extraction studies on Th(IV), Pa(V) and U(VI) from nitric acid medium using di-2-ethyl hexyl isobutyramide (D2EHIBA)", RADIOCH ACT, 86(3-4), 1999, pp. 129-134
32. Ghiso, JAA; Alonso, DF; Farias, EF; Gomez, DE; Joffe, EBD
    Deregulation of the signaling pathways controlling urokinase production - Its relationship with the invasive phenotype
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    J.A.A. Ghiso et al., "Deregulation of the signaling pathways controlling urokinase production - Its relationship with the invasive phenotype", EUR J BIOCH, 263(2), 1999, pp. 295-304
33. Scherrer, A; Wohlwend, A; Kruithof, EKO; Vassalli, JD; Sappino, AP
    Plasminogen activation in human acute leukaemias
    BRITISH JOURNAL OF HAEMATOLOGY
    
    A. Scherrer et al., "Plasminogen activation in human acute leukaemias", BR J HAEM, 105(4), 1999, pp. 920-927
34. Ahn, MY; Zhang, ZG; Tsang, W; Chopp, M
    Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice
    BRAIN RESEARCH
    
    M.Y. Ahn et al., "Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice", BRAIN RES, 837(1-2), 1999, pp. 169-176
35. Ahn, MY; Zhang, ZG; Zhang, L; Chopp, M
    The effect of age on expression of endogenous plasminogen activators afterfocal cerebral ischemia in mice
    BRAIN RESEARCH
    
    M.Y. Ahn et al., "The effect of age on expression of endogenous plasminogen activators afterfocal cerebral ischemia in mice", BRAIN RES, 833(1), 1999, pp. 112-116
36. Casslen, B; Sandberg, T; Gustavsson, B
    Progesterone induced TGF beta, stimulates stromal cell release of u-PA : PAI-1 complex, a paracrine signal for capillary endothelial cell migration; a novel mechanism in endometrial angiogenesis
    10TH WORLD CONGRESS ON HUMAN REPRODUCTION
    
    B. Casslen et al., "Progesterone induced TGF beta, stimulates stromal cell release of u-PA : PAI-1 complex, a paracrine signal for capillary endothelial cell migration; a novel mechanism in endometrial angiogenesis", 10TH WORLD CONGRESS ON HUMAN REPRODUCTION, 1999, pp. 169-174
37. MAY AE; KANSE SM; CHAVAKIS T; PREISSNER KT
    MOLECULAR-INTERACTIONS BETWEEN THE UROKINASE RECEPTOR AND INTEGRINS IN THE VASCULATURE
    FIBRINOLYSIS & PROTEOLYSIS
    
    A.E. May et al., "MOLECULAR-INTERACTIONS BETWEEN THE UROKINASE RECEPTOR AND INTEGRINS IN THE VASCULATURE", FIBRINOLYSIS & PROTEOLYSIS, 12(4), 1998, pp. 205-210
38. CASSLEN B; GUSTAVSSON B; ANGELIN B; GAFVELS M
    DEGRADATION OF UROKINASE PLASMINOGEN-ACTIVATOR (UPA) IN ENDOMETRIAL STROMAL CELLS REQUIRES BOTH THE UPA RECEPTOR AND THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN ALPHA-2-MACROGLOBULIN RECEPTOR
    Molecular human reproduction (Print)
    
    B. Casslen et al., "DEGRADATION OF UROKINASE PLASMINOGEN-ACTIVATOR (UPA) IN ENDOMETRIAL STROMAL CELLS REQUIRES BOTH THE UPA RECEPTOR AND THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN ALPHA-2-MACROGLOBULIN RECEPTOR", Molecular human reproduction (Print), 4(6), 1998, pp. 585-593
39. SWIERCZ R; WOLFE JD; ZAHER A; JANKUN J
    EXPRESSION OF THE PLASMINOGEN ACTIVATION SYSTEM IN KIDNEY CANCER CORRELATES WITH ITS AGGRESSIVE PHENOTYPE
    Clinical cancer research
    
    R. Swiercz et al., "EXPRESSION OF THE PLASMINOGEN ACTIVATION SYSTEM IN KIDNEY CANCER CORRELATES WITH ITS AGGRESSIVE PHENOTYPE", Clinical cancer research, 4(4), 1998, pp. 869-877
40. SWIERCZ R; WOLFE JD; ZAHER A; JANKUN J
    EXPRESSION OF THE PLASMINOGEN ACTIVATION SYSTEM IN KIDNEY CANCER CORRELATES WITH ITS AGGRESSIVE PHENOTYPE
    Clinical cancer research
    
    R. Swiercz et al., "EXPRESSION OF THE PLASMINOGEN ACTIVATION SYSTEM IN KIDNEY CANCER CORRELATES WITH ITS AGGRESSIVE PHENOTYPE", Clinical cancer research, 4(4), 1998, pp. 869-877
41. ISHIKAWA H; SATOH H; KAMMA H; NAITO T; OHTSUKA M; OGATA T; HASEGAWA S
    THE EFFECT OF SN-38 ON CELL-PROLIFERATION AND ON PRODUCTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR IN HUMAN LUNG-CANCER CELL-LINES
    Cancer research, therapy & control
    
    H. Ishikawa et al., "THE EFFECT OF SN-38 ON CELL-PROLIFERATION AND ON PRODUCTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR IN HUMAN LUNG-CANCER CELL-LINES", Cancer research, therapy & control, 5(2), 1998, pp. 97-105
42. KIM SJ; SHIBA E; TSUKAMOTO F; IZUKURA M; TAGUCHI T; YONEDA K; TANJI Y; KIMOTO Y; TAKAI S
    THE EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IS A NOVEL PROGNOSTIC FACTOR IN DUKES-B AND DUKES-C COLORECTAL-CANCER
    Oncology Reports
    
    S.J. Kim et al., "THE EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IS A NOVEL PROGNOSTIC FACTOR IN DUKES-B AND DUKES-C COLORECTAL-CANCER", Oncology Reports, 5(2), 1998, pp. 431-435
43. SAKUKAWA R; MURAKAMI K; IKEDA T; YAMADA Y; SAIKI I
    EFFECT OF 4-[3,5-BIS(TRIMETHYLSILYL)BENZAMIDO] BENZOIC-ACID (TAC-101)ON THE LIVER METASTASIS OF COLON 26-L5 CARCINOMA-CELLS
    Oncology research
    
    R. Sakukawa et al., "EFFECT OF 4-[3,5-BIS(TRIMETHYLSILYL)BENZAMIDO] BENZOIC-ACID (TAC-101)ON THE LIVER METASTASIS OF COLON 26-L5 CARCINOMA-CELLS", Oncology research, 10(6), 1998, pp. 287-293
44. BERNEY CR; YANG JL; FISHER RJ; RUSSELL PJ; CROWE PJ
    CORRELATES OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN COLORECTAL-CANCER - POSITIVE RELATIONSHIP WITH NM23 AND C-ERBB-2 PROTEIN EXPRESSION
    Oncology research
    
    C.R. Berney et al., "CORRELATES OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN COLORECTAL-CANCER - POSITIVE RELATIONSHIP WITH NM23 AND C-ERBB-2 PROTEIN EXPRESSION", Oncology research, 10(1), 1998, pp. 47-54
45. DEPIX MS; MARTINEZ J; SANTIBANEZ F; ROVIROSA J; SANMARTIN AS; MACCIONI RB
    THE COMPOUND 14-KETO-STYPODIOL DIACETATE FROM THE ALGAE STYPOPODIUM FLABELLIFORME INHIBITS MICROTUBULES AND CELL-PROLIFERATION IN DU-145 HUMAN PROSTATIC CELLS
    Molecular and cellular biochemistry
    
    M.S. Depix et al., "THE COMPOUND 14-KETO-STYPODIOL DIACETATE FROM THE ALGAE STYPOPODIUM FLABELLIFORME INHIBITS MICROTUBULES AND CELL-PROLIFERATION IN DU-145 HUMAN PROSTATIC CELLS", Molecular and cellular biochemistry, 187(1-2), 1998, pp. 191-199
46. LEE MJ; LEE OH; YOON SH; LEE SK; CHUNG MH; PARK YI; SUNG CK; CHOI JS; KIM KW
    IN-VITRO ANGIOGENIC ACTIVITY OF ALOE-VERA GEL ON CALF PULMONARY-ARTERY ENDOTHELIAL (CPAE) CELLS
    Archives of pharmacal research
    
    M.J. Lee et al., "IN-VITRO ANGIOGENIC ACTIVITY OF ALOE-VERA GEL ON CALF PULMONARY-ARTERY ENDOTHELIAL (CPAE) CELLS", Archives of pharmacal research, 21(3), 1998, pp. 260-265
47. HARBECK N; DETTMAR P; THOMSSEN C; HENSELMANN B; KUHN W; ULM K; JANICKE F; HOFLER H; GRAEFF H; SCHMITT M
    PROGNOSTIC IMPACT OF TUMOR BIOLOGICAL FACTORS ON SURVIVAL IN NODE-NEGATIVE BREAST-CANCER
    Anticancer research
    
    N. Harbeck et al., "PROGNOSTIC IMPACT OF TUMOR BIOLOGICAL FACTORS ON SURVIVAL IN NODE-NEGATIVE BREAST-CANCER", Anticancer research, 18(3C), 1998, pp. 2187-2197
48. BERNEY CR; YANG JL; FISHER RJ; RUSSELL PJ; CROWE PJ
    VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION IS REDUCED IN LIVER METASTASIS FROM COLORECTAL-CANCER AND CORRELATES WITH UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    Anticancer research
    
    C.R. Berney et al., "VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION IS REDUCED IN LIVER METASTASIS FROM COLORECTAL-CANCER AND CORRELATES WITH UROKINASE-TYPE PLASMINOGEN-ACTIVATOR", Anticancer research, 18(2A), 1998, pp. 973-977
49. HATANE T; YOSHIDA E; KAWANO J; SUGIKI M; ONITSUKA T; MARUYAMA M
    PROSTAGLANDIN I-2 ANALOG ENHANCES THE EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND WOUND-HEALING IN CULTURED HUMAN FIBROBLAST
    Biochimica et biophysica acta. Molecular cell research
    
    T. Hatane et al., "PROSTAGLANDIN I-2 ANALOG ENHANCES THE EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND WOUND-HEALING IN CULTURED HUMAN FIBROBLAST", Biochimica et biophysica acta. Molecular cell research, 1403(2), 1998, pp. 189-198
50. Astedt, B; Lindoff, C; Lecander, I
    Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    B. Astedt et al., "Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy", SEM THROMB, 24(5), 1998, pp. 431-435
51. MAALOE S
    EXTRACTION OF PRIMARY ABYSSAL THOLEIITE FROM A STRATIFIED PLUME
    The Journal of geology
    
    S. Maaloe, "EXTRACTION OF PRIMARY ABYSSAL THOLEIITE FROM A STRATIFIED PLUME", The Journal of geology, 106(2), 1998, pp. 163-179
52. BRUSE C; BERGQVIST A; CARLSTROM K; FIANUJONASSON A; LECANDER I; ASTEDT B
    FIBRINOLYTIC FACTORS IN ENDOMETRIOTIC TISSUE, ENDOMETRIUM, PERITONEAL-FLUID, AND PLASMA FROM WOMEN WITH ENDOMETRIOSIS AND IN ENDOMETRIUM AND PERITONEAL-FLUID FROM HEALTHY WOMEN
    Fertility and sterility
    
    C. Bruse et al., "FIBRINOLYTIC FACTORS IN ENDOMETRIOTIC TISSUE, ENDOMETRIUM, PERITONEAL-FLUID, AND PLASMA FROM WOMEN WITH ENDOMETRIOSIS AND IN ENDOMETRIUM AND PERITONEAL-FLUID FROM HEALTHY WOMEN", Fertility and sterility, 70(5), 1998, pp. 821-826
53. VANORMAN JA; GROVE TL; SHIMIZU N
    URANIUM AND THORIUM DIFFUSION IN DIOPSIDE
    Earth and planetary science letters
    
    J.A. Vanorman et al., "URANIUM AND THORIUM DIFFUSION IN DIOPSIDE", Earth and planetary science letters, 160(3-4), 1998, pp. 505-519
54. Cejkova, J
    The appearance and possible role of plasminogen activator of urokinase type (u-PA) activity in the cornea related to soft contact lens wear in rabbits
    DOCUMENTA OPHTHALMOLOGICA
    
    J. Cejkova, "The appearance and possible role of plasminogen activator of urokinase type (u-PA) activity in the cornea related to soft contact lens wear in rabbits", DOC OPHTHAL, 95(2), 1998, pp. 165-179
55. MCWILLIAM N; ROBBIE L; BOOTH N; BENNETT B
    PLASMINOGEN-ACTIVATOR IN ACUTE MYELOID LEUKEMIC MARROWS - U-PA IN CONTRAST TO T-PA IN NORMAL MARROW
    British Journal of Haematology
    
    N. Mcwilliam et al., "PLASMINOGEN-ACTIVATOR IN ACUTE MYELOID LEUKEMIC MARROWS - U-PA IN CONTRAST TO T-PA IN NORMAL MARROW", British Journal of Haematology, 101(4), 1998, pp. 626-631
56. SANDBERG T; CASSLEN B; GUSTAVSSON B; BENRAAD TJ
    HUMAN ENDOTHELIAL-CELL MIGRATION IS STIMULATED BY UROKINASE PLASMINOGEN ACTIVATOR-PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX RELEASED FROM ENDOMETRIAL STROMAL CELLS STIMULATED WITH TRANSFORMING-GROWTH-FACTOR BETA-1 - POSSIBLE MECHANISM FOR PARACRINE STIMULATION OF ENDOMETRIAL ANGIOGENESIS
    Biology of reproduction
    
    T. Sandberg et al., "HUMAN ENDOTHELIAL-CELL MIGRATION IS STIMULATED BY UROKINASE PLASMINOGEN ACTIVATOR-PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX RELEASED FROM ENDOMETRIAL STROMAL CELLS STIMULATED WITH TRANSFORMING-GROWTH-FACTOR BETA-1 - POSSIBLE MECHANISM FOR PARACRINE STIMULATION OF ENDOMETRIAL ANGIOGENESIS", Biology of reproduction, 59(4), 1998, pp. 759-767
57. CASSLEN B; SANDBERG T; GUSTAVSSON B; WILLEN R; NILBERT M
    TRANSFORMING-GROWTH-FACTOR BETA-1 IN THE HUMAN ENDOMETRIUM - CYCLIC VARIATION, INCREASED EXPRESSION BY ESTRADIOL AND PROGESTERONE, AND REGULATION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    Biology of reproduction
    
    B. Casslen et al., "TRANSFORMING-GROWTH-FACTOR BETA-1 IN THE HUMAN ENDOMETRIUM - CYCLIC VARIATION, INCREASED EXPRESSION BY ESTRADIOL AND PROGESTERONE, AND REGULATION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1", Biology of reproduction, 58(6), 1998, pp. 1343-1350
58. VANDENBURG PJM; HOSPERS JEH; VANVLIET M; MOSTERD WL; BOUMA BN; HUISVELD IA
    EFFECT OF ENDURANCE TRAINING AND SEASONAL FLUCTUATION ON COAGULATION AND FIBRINOLYSIS IN YOUNG SEDENTARY MEN
    Journal of applied physiology
    
    P.J.M. Vandenburg et al., "EFFECT OF ENDURANCE TRAINING AND SEASONAL FLUCTUATION ON COAGULATION AND FIBRINOLYSIS IN YOUNG SEDENTARY MEN", Journal of applied physiology, 82(2), 1997, pp. 613-620
59. KANSE SM; BENZAKOUR O; KANTHOU C; KOST C; LIJNEN HR; PREISSNER KT
    INDUCTION OF VASCULAR SMC PROLIFERATION BY UROKINASE INDICATES A NOVEL MECHANISM OF ACTION IN VASOPROLIFERATIVE DISORDERS
    Arteriosclerosis, thrombosis, and vascular biology
    
    S.M. Kanse et al., "INDUCTION OF VASCULAR SMC PROLIFERATION BY UROKINASE INDICATES A NOVEL MECHANISM OF ACTION IN VASOPROLIFERATIVE DISORDERS", Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2848-2854
60. WOLLENBERG B; JAN NV; JUND R; CHAUBAL S; UNTCH M
    UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR PLASMINOGEN-ACTIVATOR INHIBITOR-1 - NEW FUNCTIONAL RISK-FACTORS IN HEAD AND NECK SQUAMOUS-CELL CANCER
    Oncology Reports
    
    B. Wollenberg et al., "UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR PLASMINOGEN-ACTIVATOR INHIBITOR-1 - NEW FUNCTIONAL RISK-FACTORS IN HEAD AND NECK SQUAMOUS-CELL CANCER", Oncology Reports, 4(4), 1997, pp. 853-855
61. TAKAISHI T; UESHIMA S; MATSUO O
    NEW ASPECTS OF FIBRINOLYTIC PROTEINS IN BRAIN-DEVELOPMENT
    Cell structure and function
    
    T. Takaishi et al., "NEW ASPECTS OF FIBRINOLYTIC PROTEINS IN BRAIN-DEVELOPMENT", Cell structure and function, 22(2), 1997, pp. 225-229
62. GREWE A; ANDRIAMONJE S; BOCKSTIEGEL C; BROHM T; CLERC HG; CZAJKOWSKI S; HANELT E; HEINZ A; ITKIS MG; DEJONG M; JUNGHANS A; PRAVIKOFF MS; SCHMIDT KH; SCHWAB W; STEINHAUSER S; SUMMERER K; VOSS B
    FISSION-BARRIERS FROM ELECTROMAGNETIC FISSION OF 430-CENTER-DOT-A MEVRADIOACTIVE ION-BEAMS
    Nuclear physics. A
    
    A. Grewe et al., "FISSION-BARRIERS FROM ELECTROMAGNETIC FISSION OF 430-CENTER-DOT-A MEVRADIOACTIVE ION-BEAMS", Nuclear physics. A, 614(3), 1997, pp. 400-414
63. PREISSNER KT; MAY AE; WOHN KD; GERMER M; KANSE SM
    MOLECULAR CROSSTALK BETWEEN ADHESION RECEPTORS AND PROTEOLYTIC CASCADES IN VASCULAR REMODELING
    Thrombosis and haemostasis
    
    K.T. Preissner et al., "MOLECULAR CROSSTALK BETWEEN ADHESION RECEPTORS AND PROTEOLYTIC CASCADES IN VASCULAR REMODELING", Thrombosis and haemostasis, 78(1), 1997, pp. 88-95
64. NOWAKGOTTL U; VIELHABER H; GROHMANN J; SCHNEPPENHEIM R; KOCH HG
    ARGININE(506) TO GLUTAMIN MUTATION IN THE FACTOR-V GENE IN INFANCY AND CHILDHOOD - EVIDENCE OF FIBRINOLYTIC IMPAIRMENT
    European journal of pediatrics
    
    U. Nowakgottl et al., "ARGININE(506) TO GLUTAMIN MUTATION IN THE FACTOR-V GENE IN INFANCY AND CHILDHOOD - EVIDENCE OF FIBRINOLYTIC IMPAIRMENT", European journal of pediatrics, 156(3), 1997, pp. 195-198
65. ZHANG WJ; WOJTA J; BINDER BR
    EFFECT OF NOTOGINSENOSIDE R1 ON THE SYNTHESIS OF COMPONENTS OF THE FIBRINOLYTIC SYSTEM IN CULTURED SMOOTH-MUSCLE CELLS OF HUMAN PULMONARY-ARTERY
    Cellular and molecular biology
    
    W.J. Zhang et al., "EFFECT OF NOTOGINSENOSIDE R1 ON THE SYNTHESIS OF COMPONENTS OF THE FIBRINOLYTIC SYSTEM IN CULTURED SMOOTH-MUSCLE CELLS OF HUMAN PULMONARY-ARTERY", Cellular and molecular biology, 43(4), 1997, pp. 581-587
66. HERBERT JM; BONO F; LAMARCHE I; CARMELIET P
    THE INHIBITORY EFFECT OF HEPARIN FOR VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION OR MIGRATION IS NOT MEDIATED BY U-PA AND T-PA
    Thrombosis research
    
    J.M. Herbert et al., "THE INHIBITORY EFFECT OF HEPARIN FOR VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION OR MIGRATION IS NOT MEDIATED BY U-PA AND T-PA", Thrombosis research, 86(4), 1997, pp. 317-324
67. UMEDA T; EGUCHI Y; OKINO K; KODAMA M; HATTORI T
    CELLULAR-LOCALIZATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, ITS INHIBITORS, AND THEIR MESSENGER-RNAS IN BREAST-CANCER TISSUES
    Journal of pathology
    
    T. Umeda et al., "CELLULAR-LOCALIZATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, ITS INHIBITORS, AND THEIR MESSENGER-RNAS IN BREAST-CANCER TISSUES", Journal of pathology, 183(4), 1997, pp. 388-397
68. FRANCO P; IACCARINO C; CHIARADONNA F; BRANDAZZA A; IAVARONE C; MASTRONICOLA MR; NOLLI ML; STOPPELLI MP
    PHOSPHORYLATION OF HUMAN PROUROKINASE ON SER(138 303) IMPAIRS ITS RECEPTOR-DEPENDENT ABILITY TO PROMOTE MYELOMONOCYTIC ADHERENCE AND MOTILITY/
    The Journal of cell biology
    
    P. Franco et al., "PHOSPHORYLATION OF HUMAN PROUROKINASE ON SER(138 303) IMPAIRS ITS RECEPTOR-DEPENDENT ABILITY TO PROMOTE MYELOMONOCYTIC ADHERENCE AND MOTILITY/", The Journal of cell biology, 137(3), 1997, pp. 779-791
69. HERBERT JM; CARMELIET P
    INVOLVEMENT OF U-PA IN THE ANTI-APOPTOTIC ACTIVITY OF TGF-BETA FOR VASCULAR SMOOTH-MUSCLE CELLS
    FEBS letters
    
    J.M. Herbert e P. Carmeliet, "INVOLVEMENT OF U-PA IN THE ANTI-APOPTOTIC ACTIVITY OF TGF-BETA FOR VASCULAR SMOOTH-MUSCLE CELLS", FEBS letters, 413(3), 1997, pp. 401-404
70. ELLIOTT T
    FRACTIONATION OF U AND TH DURING MANTLE MELTING - A REPRISE
    Chemical geology
    
    T. Elliott, "FRACTIONATION OF U AND TH DURING MANTLE MELTING - A REPRISE", Chemical geology, 139(1-4), 1997, pp. 165-183
71. HACKEL C; CZERNIAK B; AYALA AG; RADIG K; ROESSNER A
    EXPRESSION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN DEDIFFERENTIATED CHONDROSARCOMA
    Cancer
    
    C. Hackel et al., "EXPRESSION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN DEDIFFERENTIATED CHONDROSARCOMA", Cancer, 79(1), 1997, pp. 53-58
72. BENNETT B; CROLL AM; ROBBIE LA; HERRIOT R
    TUMOR-CELL U-PA AS A CAUSE OF FIBRINOLYTIC BLEEDING IN METASTATIC DISEASE
    British Journal of Haematology
    
    B. Bennett et al., "TUMOR-CELL U-PA AS A CAUSE OF FIBRINOLYTIC BLEEDING IN METASTATIC DISEASE", British Journal of Haematology, 99(3), 1997, pp. 570-574
73. GIBSON PR; ROSELLA O
    ABNORMALITIES OF THE UROKINASE SYSTEM IN COLONIC CRYPT CELLS FROM PATIENTS WITH ULCERATIVE-COLITIS
    Inflammatory bowel diseases
    
    P.R. Gibson e O. Rosella, "ABNORMALITIES OF THE UROKINASE SYSTEM IN COLONIC CRYPT CELLS FROM PATIENTS WITH ULCERATIVE-COLITIS", Inflammatory bowel diseases, 2(2), 1996, pp. 105-114
74. MUKHERJEE M; SEMBHI K; KAKKAR VV
    INTERFERENCE OF AN ACTIVITY ASSAY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN PLASMA BY ENDOGENOUS FACTORS
    Blood coagulation & fibrinolysis
    
    M. Mukherjee et al., "INTERFERENCE OF AN ACTIVITY ASSAY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN PLASMA BY ENDOGENOUS FACTORS", Blood coagulation & fibrinolysis, 7(4), 1996, pp. 491-496
75. NORDENGREN J; CASSLEN B; LECANDER I
    PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN MENSTRUAL ENDOMETRIUM AND IN PRIMARY CULTURES OF ENDOMETRIAL CELLS
    Fibrinolysis
    
    J. Nordengren et al., "PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN MENSTRUAL ENDOMETRIUM AND IN PRIMARY CULTURES OF ENDOMETRIAL CELLS", Fibrinolysis, 10(5-6), 1996, pp. 295-302
76. KLUFT C; MEIJER P
    UPDATE 1996 - BLOOD COLLECTION AND HANDLING PROCEDURES FOR ASSESSMENTOF PLASMINOGEN ACTIVATORS AND INHIBITORS (LEIDEN FIBRINOLYSIS WORKSHOP)
    Fibrinolysis
    
    C. Kluft e P. Meijer, "UPDATE 1996 - BLOOD COLLECTION AND HANDLING PROCEDURES FOR ASSESSMENTOF PLASMINOGEN ACTIVATORS AND INHIBITORS (LEIDEN FIBRINOLYSIS WORKSHOP)", Fibrinolysis, 10, 1996, pp. 171-179
77. MATSUMOTO H; UESHIMA S; FUKAO H; MITSUI Y; MATSUO O
    EFFECTS OF LIPOPOLYSACCHARIDE ON THE EXPRESSION OF FIBRINOLYTIC FACTORS IN AN ESTABLISHED CELL-LINE FROM HUMAN ENDOTHELIAL-CELLS
    Life sciences
    
    H. Matsumoto et al., "EFFECTS OF LIPOPOLYSACCHARIDE ON THE EXPRESSION OF FIBRINOLYTIC FACTORS IN AN ESTABLISHED CELL-LINE FROM HUMAN ENDOTHELIAL-CELLS", Life sciences, 59(2), 1996, pp. 85-96
78. YEBRA M; PARRY GCN; STROMBLAD S; MACKMAN N; ROSENBERG S; MUELLER BM; CHERESH DA
    REQUIREMENT OF RECEPTOR-BOUND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR FOR INTEGRIN ALPHA-V-BETA-5-DIRECTED CELL-MIGRATION
    The Journal of biological chemistry
    
    M. Yebra et al., "REQUIREMENT OF RECEPTOR-BOUND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR FOR INTEGRIN ALPHA-V-BETA-5-DIRECTED CELL-MIGRATION", The Journal of biological chemistry, 271(46), 1996, pp. 29393-29399
79. HOFMANN R; LEHMER A; BURESCH M; HARTUNG R; ULM K
    CLINICAL RELEVANCE OF UROKINASE PLASMINOGEN-ACTIVATOR, ITS RECEPTOR, AND ITS INHIBITOR IN PATIENTS WITH RENAL-CELL CARCINOMA
    Cancer
    
    R. Hofmann et al., "CLINICAL RELEVANCE OF UROKINASE PLASMINOGEN-ACTIVATOR, ITS RECEPTOR, AND ITS INHIBITOR IN PATIENTS WITH RENAL-CELL CARCINOMA", Cancer, 78(3), 1996, pp. 487-492
80. HIGAZI AAR; UPSON RH; COHEN RL; MANUPPELLO J; BOGNACKI J; HENKIN J; MCCRAE KR; KOUNNAS MZ; STRICKLAND DK; PREISSNER KT; LAWLER J; CINES DB
    INTERACTION OF SINGLE-CHAIN UROKINASE WITH ITS RECEPTOR INDUCES THE APPEARANCE AND DISAPPEARANCE OF BINDING EPITOPES WITHIN THE RESULTANT COMPLEX FOR OTHER CELL-SURFACE PROTEINS
    Blood
    
    A.A.R. Higazi et al., "INTERACTION OF SINGLE-CHAIN UROKINASE WITH ITS RECEPTOR INDUCES THE APPEARANCE AND DISAPPEARANCE OF BINDING EPITOPES WITHIN THE RESULTANT COMPLEX FOR OTHER CELL-SURFACE PROTEINS", Blood, 88(2), 1996, pp. 542-551
81. ITAYA T; SUZUKI K; TAKAGI I; MOTAI H; BABA S
    RELATIONSHIP BETWEEN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS AND FIBRINOLYTIC FACTORS - IMMUNOHISTOLOGICAL STUDY
    Acta oto-laryngologica
    
    T. Itaya et al., "RELATIONSHIP BETWEEN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS AND FIBRINOLYTIC FACTORS - IMMUNOHISTOLOGICAL STUDY", Acta oto-laryngologica, 1996, pp. 113-119
82. ITO Y; TAKEDA T; WAKASUGI E; UMESHITA K; FUKUDA H; MONDEN T; KOBAYASHI T; SHIMANO T; MONDEN M
    EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN VARIOUS HUMAN THYROID TISSUES
    Oncology Reports
    
    Y. Ito et al., "EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN VARIOUS HUMAN THYROID TISSUES", Oncology Reports, 2(4), 1995, pp. 525-528
83. MATSUMOTO H; UESHIMA S; FUKAO H; MITSUI Y; MATSUO O
    IDENTIFICATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR IN HUMAN ENDOTHELIAL-CELLS AND ITS MODULATION BY PHORBOL-MYRISTATE ACETATE
    Cell structure and function
    
    H. Matsumoto et al., "IDENTIFICATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR IN HUMAN ENDOTHELIAL-CELLS AND ITS MODULATION BY PHORBOL-MYRISTATE ACETATE", Cell structure and function, 20(6), 1995, pp. 429-437
84. NONAKA T; MATSUMOTO H; SHIMADA W; MIYAGI I; OKADA K; FUKAO H; UESHIMA S; KIKUCHI H; TANAKA S; MATSUO O
    EFFECT OF CYCLIC-AMP ON UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTORAND FIBRINOLYTIC FACTORS IN A HUMAN OSTEOBLAST-LIKE CELL-LINE
    Biochimica et biophysica acta. Molecular cell research
    
    T. Nonaka et al., "EFFECT OF CYCLIC-AMP ON UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTORAND FIBRINOLYTIC FACTORS IN A HUMAN OSTEOBLAST-LIKE CELL-LINE", Biochimica et biophysica acta. Molecular cell research, 1266(1), 1995, pp. 50-56
85. CEJKOVA J; LOJDA Z
    THE APPEARANCE OF ACTIVE PLASMINOGEN-ACTIVATOR OF UROKINASE-TYPE (U-PA) IN THE RABBIT ANTERIOR EYE SEGMENT IRRADIATED BY UVB RAYS - A HISTOCHEMICAL AND BIOCHEMICAL-STUDY
    Acta histochemica
    
    J. Cejkova e Z. Lojda, "THE APPEARANCE OF ACTIVE PLASMINOGEN-ACTIVATOR OF UROKINASE-TYPE (U-PA) IN THE RABBIT ANTERIOR EYE SEGMENT IRRADIATED BY UVB RAYS - A HISTOCHEMICAL AND BIOCHEMICAL-STUDY", Acta histochemica, 97(3), 1995, pp. 257-262
86. FRIST ST; TAYLOR HA; KIRK KA; GRAMMER JR; LI XN; GRENETT HE; BOOYSE FM
    EXPRESSION OF PAI-1, T-PA AND U-PA IN CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS DERIVED FROM RACIAL GROUPS
    Thrombosis research
    
    S.T. Frist et al., "EXPRESSION OF PAI-1, T-PA AND U-PA IN CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS DERIVED FROM RACIAL GROUPS", Thrombosis research, 77(3), 1995, pp. 279-290
87. AKA AK; BARCI V; ARDISSON G; RIGHETTI R; LEDU JF; TRUBERT D
    REINVESTIGATION OF DECAY PROPERTIES OF NUCLEI BELONGING TO THE U-230 SERIES USING CONTINUOUS RADIOCHEMICAL SEPARATIONS
    Radiochimica Acta
    
    A.K. Aka et al., "REINVESTIGATION OF DECAY PROPERTIES OF NUCLEI BELONGING TO THE U-230 SERIES USING CONTINUOUS RADIOCHEMICAL SEPARATIONS", Radiochimica Acta, 68(3), 1995, pp. 155-160
88. BOXMAN ILA; QUAX PHA; LOWIK CWGM; PAPAPOULOS SE; VERHEIJEN J; PONEC M
    DIFFERENTIAL REGULATION OF PLASMINOGEN ACTIVATION IN NORMAL KERATINOCYTES AND SCC-4 CELLS BY FIBROBLASTS
    Journal of investigative dermatology
    
    I.L.A. Boxman et al., "DIFFERENTIAL REGULATION OF PLASMINOGEN ACTIVATION IN NORMAL KERATINOCYTES AND SCC-4 CELLS BY FIBROBLASTS", Journal of investigative dermatology, 104(3), 1995, pp. 374-378
89. CHANDLER WL; LEVY WC; STRATTON JR
    THE CIRCULATORY REGULATION OF TPA AND UPA SECRETION, CLEARANCE, AND INHIBITION DURING EXERCISE AND DURING THE INFUSION OF ISOPROTERENOL ANDPHENYLEPHRINE
    Circulation
    
    W.L. Chandler et al., "THE CIRCULATORY REGULATION OF TPA AND UPA SECRETION, CLEARANCE, AND INHIBITION DURING EXERCISE AND DURING THE INFUSION OF ISOPROTERENOL ANDPHENYLEPHRINE", Circulation, 92(10), 1995, pp. 2984-2994
90. WADA K; TAKAHASHI H; HANANO M; TATEWAKI W; NIWANO H; SEKI Y; SHIBATA A
    PLASMA UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH LEUKEMIAS
    Leukemia & lymphoma
    
    K. Wada et al., "PLASMA UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH LEUKEMIAS", Leukemia & lymphoma, 15(5-6), 1994, pp. 499-502
91. WILL C; WILHELM O; HOHL S; MOBUS V; WEIDLE U; KREIENBERG R; JANICKE F; SCHMITT M; GRAEFF H
    EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS RECEPTOR (UPAR) IN HUMAN OVARIAN-CANCER CELLS AND IN-VITRO INVASION CAPACITY
    International journal of oncology
    
    C. Will et al., "EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS RECEPTOR (UPAR) IN HUMAN OVARIAN-CANCER CELLS AND IN-VITRO INVASION CAPACITY", International journal of oncology, 5(4), 1994, pp. 753-761
92. SATO S; HIGASHI T; OUGUCHI S; HINO N; TSUJI T
    ELEVATED UROKINASE-TYPE PLASMINOGEN-ACTIVATOR PLASMA-LEVELS ARE ASSOCIATED WITH DETERIORATION OF LIVER-FUNCTION BUT NOT WITH HEPATOCELLULAR-CARCINOMA
    Journal of gastroenterology
    
    S. Sato et al., "ELEVATED UROKINASE-TYPE PLASMINOGEN-ACTIVATOR PLASMA-LEVELS ARE ASSOCIATED WITH DETERIORATION OF LIVER-FUNCTION BUT NOT WITH HEPATOCELLULAR-CARCINOMA", Journal of gastroenterology, 29(6), 1994, pp. 745-750
93. WILHELM O; REUNING U; JANICKE F; SCHMITT M; GRAEFF H
    THE ROLE OF PROTEASES IN TUMOR INVASION AND METASTASIS - PROGNOSTIC IMPACT AND THERAPEUTIC CHALLENGE
    Onkologie
    
    O. Wilhelm et al., "THE ROLE OF PROTEASES IN TUMOR INVASION AND METASTASIS - PROGNOSTIC IMPACT AND THERAPEUTIC CHALLENGE", Onkologie, 17(4), 1994, pp. 358-366
94. QUAX PHA; BOXMAN LA; VANKESTEREN CAM; VERHEIJEN JH; PONEC M
    PLASMINOGEN ACTIVATORS ARE INVOLVED IN KERATINOCYTE AND FIBROBLAST MIGRATION IN WOUNDED CULTURES IN-VITRO
    Fibrinolysis
    
    P.H.A. Quax et al., "PLASMINOGEN ACTIVATORS ARE INVOLVED IN KERATINOCYTE AND FIBROBLAST MIGRATION IN WOUNDED CULTURES IN-VITRO", Fibrinolysis, 8(4), 1994, pp. 221-228
95. KOOK YH; ADAMSKI J; ZELENT A; OSSOWSKI L
    THE EFFECT OF ANTISENSE INHIBITION OF UROKINASE RECEPTOR IN HUMAN SQUAMOUS-CELL CARCINOMA ON MALIGNANCY
    EMBO journal
    
    Y.H. Kook et al., "THE EFFECT OF ANTISENSE INHIBITION OF UROKINASE RECEPTOR IN HUMAN SQUAMOUS-CELL CARCINOMA ON MALIGNANCY", EMBO journal, 13(17), 1994, pp. 3983-3991
96. MARTINEZ J; SANTIBANEZ JF
    SURFACE-ASSOCIATED PLASMINOGEN ACTIVATION IN LEUKEMIC-CELLS - INTERACTION WITH EXTRACELLULAR-MATRIX
    European journal of cell biology
    
    J. Martinez e J.F. Santibanez, "SURFACE-ASSOCIATED PLASMINOGEN ACTIVATION IN LEUKEMIC-CELLS - INTERACTION WITH EXTRACELLULAR-MATRIX", European journal of cell biology, 64(2), 1994, pp. 257-263
97. OKA K; TSUDA H; SAKAMOTO S; GO Y; TOMONAGA M
    PLASMINOGEN-ACTIVATOR AND HEMORRHAGE IN BRAIN-TUMORS
    Journal of neuro-oncology
    
    K. Oka et al., "PLASMINOGEN-ACTIVATOR AND HEMORRHAGE IN BRAIN-TUMORS", Journal of neuro-oncology, 22(2), 1994, pp. 183-187
98. TAKADA Y; URANO T; TAKADA A
    EFFECTS OF HEPARIN SULFATE ANALOG OR OTHER SULFATED POLYSACCHARIDES ON THE ACTIVATION OF PLASMINOGEN BY T-PA OR U-PA
    Thrombosis research
    
    Y. Takada et al., "EFFECTS OF HEPARIN SULFATE ANALOG OR OTHER SULFATED POLYSACCHARIDES ON THE ACTIVATION OF PLASMINOGEN BY T-PA OR U-PA", Thrombosis research, 73(5), 1994, pp. 301-311
99. NAGAYAMA M; SATO A; HAYAKAWA H; URANO T; TAKADA Y; TAKADA A
    PLASMINOGEN ACTIVATORS AND THEIR INHIBITORS IN NONSMALL CELL LUNG-CANCER - LOW CONTENT OF TYPE-2 PLASMINOGEN-ACTIVATOR INHIBITOR ASSOCIATEDWITH TUMOR DISSEMINATION
    Cancer
    
    M. Nagayama et al., "PLASMINOGEN ACTIVATORS AND THEIR INHIBITORS IN NONSMALL CELL LUNG-CANCER - LOW CONTENT OF TYPE-2 PLASMINOGEN-ACTIVATOR INHIBITOR ASSOCIATEDWITH TUMOR DISSEMINATION", Cancer, 73(5), 1994, pp. 1398-1405
100. VANDEWERF F; LIJNEN HR; COLLEN D
     CORONARY THROMBOLYSIS WITH K(1)K(2)P(U), A CHIMERIC TISSUE-TYPE AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - A FEASIBILITY STUDY IN 6 PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
     Coronary artery disease
     
     F. Vandewerf et al., "CORONARY THROMBOLYSIS WITH K(1)K(2)P(U), A CHIMERIC TISSUE-TYPE AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - A FEASIBILITY STUDY IN 6 PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION", Coronary artery disease, 4(10), 1993, pp. 929-933